Rolapitant Hydrochloride

CAS 552292-08-7 3 FDA-DMF suppliersSmall Molecule

Overview

Rolapitant Hydrochloride is a selective neurokinin-1 (NK1) receptor antagonist used as an antiemetic to prevent chemotherapy-induced nausea and vomiting. It functions by blocking the action of neurokinin, a chemical in the brain involved in triggering nausea and vomiting.

Therapeutic areas

OncologyGastroenterologySupportive Care

Related APIs

Octreotide Acetate
20 suppliers
Granisetron Hydrochloride
13 suppliers
Regorafenib
8 suppliers
Ondansetron Hydrochloride
5 suppliers
Dolasetron Mesylate
4 suppliers
Pantoprazole
53 suppliers
Lansoprazole
35 suppliers
Paclitaxel
33 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo